According to the research report, the global cell-based assays market size is expected to touch USD 42.32 Billion by 2032, from USD 17.83 Billion in 2022, growing with a significant CAGR of 9.03% from 2023 to 2032.
The cell-based assays report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global cell-based assays in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global cell-based assays market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global cell-based assays during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/2982
This study covers a detailed segmentation of the global cell-based assays market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global cell-based assays market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- Danaher Corporation
- Lonza Group AG
- Promega Corporation
- F. Hoffmann-La Roche AG
- Charles River Laboratories International, Inc.
- Menarini Silicon Biosystems, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Macrogen Inc
- DiscoverX Corporation
- Corning Inc.
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Perkinelmer, Inc.
- Biognosys
- Cell Signaling Technology, Inc.
- Lebermuth, Inc.
- Eurofins DiscoverX Products
- AAT Bioquest, Inc.
- GE Healthcare
- Beckman Coulter,Inc.
Market Segmentation
By Type
- Cell Viability Assay
- Cytotoxicity Assay
- Cell Death Assay
- Cell Proliferation Assay
- Others
By Products & Services
- Reagents
- Assay Kits
- Cell Growth Assays
- Reporter Gene Assays
- Cell Death Assays
- Second Messenger Assays
- Microplates
- Probes & Labels
- Instruments & Software
- Cell Lines
- Primary Cell Lines
- Stem Cell Lines
- Immortalized Cell Lines
By Application
- Basic Research
- Drug Discovery
- Other Applications
By Technology
- Automated Handling
- Flow Cytometry
- Label-free Detection
- High-throughput Screening
- Others
By End-use
- Pharmaceutical and Biotechnology Companies
- Academic & Government Institutes
- Contract Research Organizations
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global cell-based assays report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global cell-based assays market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cell-based Assays Market
5.1. COVID-19 Landscape: Cell-based Assays Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cell-based Assays Market, By Type
8.1. Cell-based Assays Market, by Type, 2023-2032
8.1.1. Cell Viability Assay
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Cytotoxicity Assay
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Cell Death Assay
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Cell Proliferation Assay
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Cell-based Assays Market, By Products & Services
9.1. Cell-based Assays Market, by Products & Services, 2023-2032
9.1.1. Reagents
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Assay Kits
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Microplates
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Probes & Labels
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Instruments & Software
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Cell Lines
9.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Cell-based Assays Market, By Application
10.1. Cell-based Assays Market, by Application, 2023-2032
10.1.1. Basic Research
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Drug Discovery
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Other Applications
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Cell-based Assays Market, By Technology
11.1. Cell-based Assays Market, by Technology, 2023-2032
11.1.1. Automated Handling
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Flow Cytometry
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Label-free Detection
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. High-throughput Screening
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Cell-based Assays Market, By End-use
12.1. Cell-based Assays Market, by End-use, 2023-2032
12.1.1. Pharmaceutical and Biotechnology Companies
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Academic & Government Institutes
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Contract Research Organizations
12.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Cell-based Assays Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type (2020-2032)
13.1.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.1.3. Market Revenue and Forecast, by Application (2020-2032)
13.1.4. Market Revenue and Forecast, by Technology (2020-2032)
13.1.5. Market Revenue and Forecast, by End-use (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
13.1.6.4. Market Revenue and Forecast, by Technology (2020-2032)
13.1.6.5. Market Revenue and Forecast, by End-use (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Type (2020-2032)
13.1.7.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.1.7.3. Market Revenue and Forecast, by Application (2020-2032)
13.1.7.4. Market Revenue and Forecast, by Technology (2020-2032)
13.1.7.5. Market Revenue and Forecast, by End-use (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2020-2032)
13.2.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.2.3. Market Revenue and Forecast, by Application (2020-2032)
13.2.4. Market Revenue and Forecast, by Technology (2020-2032)
13.2.5. Market Revenue and Forecast, by End-use (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
13.2.7. Market Revenue and Forecast, by Technology (2020-2032)
13.2.8. Market Revenue and Forecast, by End-use (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Application (2020-2032)
13.2.10. Market Revenue and Forecast, by Technology (2020-2032)
13.2.11. Market Revenue and Forecast, by End-use (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Application (2020-2032)
13.2.12.4. Market Revenue and Forecast, by Technology (2020-2032)
13.2.13. Market Revenue and Forecast, by End-use (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Application (2020-2032)
13.2.14.4. Market Revenue and Forecast, by Technology (2020-2032)
13.2.15. Market Revenue and Forecast, by End-use (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2020-2032)
13.3.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.3.3. Market Revenue and Forecast, by Application (2020-2032)
13.3.4. Market Revenue and Forecast, by Technology (2020-2032)
13.3.5. Market Revenue and Forecast, by End-use (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
13.3.6.4. Market Revenue and Forecast, by Technology (2020-2032)
13.3.7. Market Revenue and Forecast, by End-use (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
13.3.8.4. Market Revenue and Forecast, by Technology (2020-2032)
13.3.9. Market Revenue and Forecast, by End-use (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Application (2020-2032)
13.3.10.4. Market Revenue and Forecast, by Technology (2020-2032)
13.3.10.5. Market Revenue and Forecast, by End-use (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Application (2020-2032)
13.3.11.4. Market Revenue and Forecast, by Technology (2020-2032)
13.3.11.5. Market Revenue and Forecast, by End-use (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2020-2032)
13.4.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.4.3. Market Revenue and Forecast, by Application (2020-2032)
13.4.4. Market Revenue and Forecast, by Technology (2020-2032)
13.4.5. Market Revenue and Forecast, by End-use (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
13.4.6.4. Market Revenue and Forecast, by Technology (2020-2032)
13.4.7. Market Revenue and Forecast, by End-use (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
13.4.8.4. Market Revenue and Forecast, by Technology (2020-2032)
13.4.9. Market Revenue and Forecast, by End-use (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Application (2020-2032)
13.4.10.4. Market Revenue and Forecast, by Technology (2020-2032)
13.4.10.5. Market Revenue and Forecast, by End-use (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Application (2020-2032)
13.4.11.4. Market Revenue and Forecast, by Technology (2020-2032)
13.4.11.5. Market Revenue and Forecast, by End-use (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type (2020-2032)
13.5.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.5.3. Market Revenue and Forecast, by Application (2020-2032)
13.5.4. Market Revenue and Forecast, by Technology (2020-2032)
13.5.5. Market Revenue and Forecast, by End-use (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
13.5.6.4. Market Revenue and Forecast, by Technology (2020-2032)
13.5.7. Market Revenue and Forecast, by End-use (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Products & Services (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Application (2020-2032)
13.5.8.4. Market Revenue and Forecast, by Technology (2020-2032)
13.5.8.5. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 14. Company Profiles
14.1. Danaher Corporation
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Lonza Group AG
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Promega Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. F. Hoffmann-La Roche AG
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Charles River Laboratories International, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Menarini Silicon Biosystems, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Becton, Dickinson and Company
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Bio-Rad Laboratories, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Macrogen Inc
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. DiscoverX Corporation
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments